Concepedia

J. Nathaniel Diehl

JN

Statistics

Publications

21

Citations

1.9K

H-Index

19

Active since

2013

Affiliations

University of North Carolina at Chapel Hill(Current)

George Mason University

Dana-Farber Cancer Institute

Broad Institute

Harvard University

J. Nathaniel Diehl is an author at University of North Carolina at Chapel Hill specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2013–2024

21

Publications

21

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant, Clint A. Stalnecker, Daniel Zeitouni et al. · Nature Medicine · 2019 · 715 citations

, , +16

Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

G. Aaron Hobbs, Nicole M. Baker, Anne M. Miermont et al. · Cancer Discovery · 2019 · 226 citations · Full text

, , +12

Gain-of-Function <i>RHOA</i> Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer

Haisheng Zhang, Antje Schaefer, Yichen Wang et al. · Cancer Discovery · 2019 · 173 citations · Full text

, , +17

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

Jeffrey A. Klomp, Jeffrey A. Klomp, Jennifer E. Klomp et al. · Science · 2024 · 108 citations · Full text

, , +17

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George et al. · Cell Reports · 2020 · 107 citations · Full text

, , +17

1–5 of 21